PRODUCT MANAGEMENT

Know what changed before the portfolio review.

Use RateFileAI to track observed filing movement, open the underlying record, and keep a competitive review tied to evidence.

ILLUSTRATIVE REVIEW FRAME
Question → record → review
source stays attached
DECLARED SCOPEcarrier · line · state · period
01Frame the questionname the market and time scope
02Inspect the recordreview rows, dates, and source route
03Carry the reviewleave the next check explicit
Observedfiling movement, status, dates, source
Boundaryheld-corpus coverage can be incomplete

Example pathway. It shows the shape of a review, not a measured portfolio result.

A CLEAR STARTING POINT

Keep the portfolio question narrow enough to review.

Start with a defined carrier, line, jurisdiction, and period. The role lens changes emphasis and vocabulary; it does not grant access or replace the source-backed product path.

WORK PATH
A competitive review with the record open
evidence first
QUESTIONWhat changed in the selected market?Name the scope before reading the result.01
RECORDFiling rows, requested and filed fields, dates, status, and source routeThe source record remains the review point.02
REVIEWA note or next check that keeps the evidence attachedDo not turn an absent record into a market conclusion.03

The same evidence chain supports product, pricing, and portfolio conversations without implying a role-specific dataset.

WHAT THIS LENS IS FOR

Make the portfolio conversation easier to inspect.

RateFileAI keeps the review question, the returned record, and the known boundary in the same frame.

Competitive review

See where a selected carrier or product appears in the held filing record.

Context that travels

Keep jurisdiction, filing type, period, and source beside the comparison.

A cleaner handoff

Carry the finding into a review note when the connected path is available.

BOUNDARY

Use the filing for what it can support.

Public records can be delayed, incomplete, or absent from the held corpus. RateFileAI keeps those limits visible instead of substituting a generic market conclusion.

Search filingsReview coverage